Merit Medical Systems Free Cash Flow 2010-2024 | MMSI

Merit Medical Systems free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Merit Medical Systems Annual Free Cash Flow
2023 111.06
2022 69.33
2021 120.33
2020 119.32
2019 0.56
2018 23.26
2017 24.13
2016 20.78
2015 19.75
2014 19.24
2013 -8.02
2012 -17.66
2011 -25.18
2010 11.13
2009 11.62
Merit Medical Systems Quarterly Free Cash Flow
2024-03-31 24.53
2023-12-31 111.06
2023-09-30 55.93
2023-06-30 13.48
2023-03-31 1.96
2022-12-31 69.33
2022-09-30 53.81
2022-06-30 34.09
2022-03-31 2.48
2021-12-31 120.33
2021-09-30 82.84
2021-06-30 64.51
2021-03-31 29.93
2020-12-31 119.32
2020-09-30 92.80
2020-06-30 47.44
2020-03-31 14.91
2019-12-31 0.56
2019-09-30 -6.94
2019-06-30 -0.25
2019-03-31 -4.75
2018-12-31 23.26
2018-09-30 15.84
2018-06-30 3.49
2018-03-31 -8.30
2017-12-31 24.13
2017-09-30 13.88
2017-06-30 16.79
2017-03-31 5.00
2016-12-31 20.78
2016-09-30 9.85
2016-06-30 4.22
2016-03-31 0.59
2015-12-31 19.75
2015-09-30 17.55
2015-06-30 15.02
2015-03-31 9.78
2014-12-31 19.24
2014-09-30 7.39
2014-06-30 1.44
2014-03-31 -0.73
2013-12-31 -8.02
2013-09-30 -14.34
2013-06-30 -15.97
2013-03-31 -17.06
2012-12-31 -17.66
2012-09-30 -17.09
2012-06-30 -13.18
2012-03-31 -10.25
2011-12-31 -25.18
2011-09-30 -8.37
2011-06-30 -8.04
2011-03-31 -3.94
2010-12-31 11.13
2010-09-30 5.05
2010-06-30 6.11
2010-03-31 0.76
2009-12-31 11.62
2009-09-30 8.47
2009-06-30 8.83
2009-03-31 6.03
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $4.758B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.379B 20.59
Becton Dickinson (BDX) United States $68.292B 19.32
West Pharmaceutical Services (WST) United States $25.906B 46.43
Cardinal Health (CAH) United States $24.133B 13.80
Align Technology (ALGN) United States $20.439B 39.46
Cooper (COO) United States $19.341B 29.27
Labcorp (LH) United States $17.753B 15.28
Henry Schein (HSIC) United States $9.553B 16.99
DENTSPLY SIRONA (XRAY) United States $5.872B 15.20
Patterson (PDCO) United States $2.308B 11.06
CONMED (CNMD) United States $2.301B 20.87
STAAR Surgical (STAA) United States $2.098B 80.57
Atrion (ATRI) United States $0.819B 43.73
Lifevantage (LFVN) United States $0.086B 11.11
Pro-Dex (PDEX) United States $0.067B 33.62
Biolase (BIOL) United States $0.005B 0.00